KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$44.94
-1.10 (-2.39%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+61.7% upside
Low Target
$47.11
Average Target
$72.69
High Target
$100.82
Current Price
$44.94
Current
$44.94
$44.94
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Scenario Analysis
Bear Case
$47.11
4.8%
Low target
Base Case
$72.69
+61.7%
Avg target
Bull Case
$100.82
+124.3%
High target
Risk/Reward
25.8x
Highly favorable
Price in Context
52-Week High
$49.12
-8.5% from high
52-Week Low
$18.26
+146.2% from low
50-Day SMA
$42.51
+5.7% vs SMA
200-Day SMA
$35.71
+25.8% vs SMA
RSI (14)
68.7
Neutral
Target vs 52W High
$72.69
+48.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +25.5% |
| AMGN | Hold | 42 | 50% | $190.87 | -45.2% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.6% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.6% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -66.8% |
| INSM | Strong Buy | 26 | 92% | $143.40 | +3.1% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -26.5% |